H.R. 307 · 119th Congress · Health
ARC Act of 2025
- IntroducedJan 9, 2025 Done
- CommitteeReferred to 2 committees Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill provides for coverage of peripheral artery disease screening tests without cost-sharing under Medicare and Medicaid for certain at-risk individuals. It also requires the development of certain educational programs, a payment model, and Medicare quality measures to reduce amputations relating to such disease.
Congressional Research Service · summary of “Introduced in House” version · Jan 9, 2025
Who lobbies on it
5 organizations · 31 filings · Q1 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Medtronic (cardiovascular Coalition)
7 of 7 quarters
“Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026”
-
American College of Cardiology
7 of 7 quarters
“Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for…”
-
Cardiovascular Coalition
7 of 7 quarters
“Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; H.R. 307 - ARC Act of 2025; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024; H.R. 9693 - Patients First Act of 2026”
2 more organizations, every filingPROUpgrade
Organizations that named H.R. 307 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.
Actions
3 actions · newest first- Jan 14, 2025Sponsor introductory remarks on measure. (CR H122)
- Jan 9, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jan 9, 2025Introduced in House